
Pharmacally
sanofi
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in sanofi
Clinical TrialsSanofi Reports Phase 3 Success for Amlitelimab in Atopic DermatitisAmlitelimab met primary endpoints across three Phase 3 trials in moderate-to-severe atopic dermatitis, showing consistent improvements in skin clearance, disease severity, and itch with a favorable safety profile.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.